Kissei Pharmaceutical Co., Ltd. (TYO:4547)

Kissei Pharmaceutical Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	36,324	25,169	22,894	25,893	30,013	20,456
Short-Term Investments	25,374	23,485	23,039	23,706	23,139	23,998
Cash & Short-Term Investments	61,698	48,654	45,933	49,599	53,152	44,454
Cash Growth	23.49%	5.92%	-7.39%	-6.69%	19.57%	-25.50%
Receivables	28,344	28,951	27,790	22,083	21,956	23,058
Inventory	26,241	24,979	26,296	22,798	18,987	20,118
Other Current Assets	3,593	4,396	4,532	6,161	5,247	5,335
Total Current Assets	119,876	106,980	104,551	100,641	99,342	92,965
Property, Plant & Equipment	29,762	27,069	24,861	24,579	24,074	24,290
Long-Term Investments	108,985	107,544	128,910	94,034	112,574	149,365
Goodwill	-	242	309	-	-	-
Other Intangible Assets	2,005	1,652	1,683	1,507	1,569	1,640
Long-Term Deferred Tax Assets	496	566	608	433	524	585
Other Long-Term Assets	1	1	2	1	1	2
Total Assets	261,125	244,059	260,929	221,200	238,087	268,861
Accounts Payable	7,756	4,602	4,893	4,617	4,104	7,909
Accrued Expenses	1,873	2,192	1,856	1,679	1,721	1,830
Short-Term Debt	1,270	1,280	1,340	1,490	1,640	1,743
Current Income Taxes Payable	5,095	1,474	2,380	408	3,497	1,487
Other Current Liabilities	17,581	7,030	7,194	6,763	7,782	5,276
Total Current Liabilities	33,575	16,578	17,663	14,957	18,744	18,245
Pension & Post-Retirement Benefits	211	202	209	192	181	1,398
Long-Term Deferred Tax Liabilities	14,082	16,481	21,188	10,426	16,259	28,480
Other Long-Term Liabilities	633	673	735	812	724	786
Total Liabilities	48,501	33,934	39,795	26,387	35,908	48,909
Common Stock	24,356	24,356	24,356	24,356	24,356	24,356
Additional Paid-In Capital	24,243	24,226	24,226	24,226	24,226	24,226
Retained Earnings	132,746	131,488	127,310	125,576	118,183	109,270
Treasury Stock	-15,513	-14,520	-13,209	-12,912	-12,912	-12,911
Comprehensive Income & Other	45,547	43,453	57,344	32,653	47,532	74,373
Total Common Equity	211,379	209,003	220,027	193,899	201,385	219,314
Minority Interest	1,245	1,122	1,107	914	794	638
Shareholders' Equity	212,624	210,125	221,134	194,813	202,179	219,952
Total Liabilities & Equity	261,125	244,059	260,929	221,200	238,087	268,861
Total Debt	1,270	1,280	1,340	1,490	1,640	1,743
Net Cash (Debt)	60,428	47,374	44,593	48,109	51,512	42,711
Net Cash Growth	24.08%	6.24%	-7.31%	-6.61%	20.61%	-26.25%
Net Cash Per Share	1426.69	1086.01	985.30	1043.24	1117.03	915.25
Filing Date Shares Outstanding	41.45	41.44	44.21	45.96	46.12	46.12
Total Common Shares Outstanding	41.45	42.81	44.21	46.12	46.12	46.12
Working Capital	86,301	90,402	86,888	85,684	80,598	74,720
Book Value Per Share	5099.29	4882.67	4977.38	4204.63	4366.94	4755.71
Tangible Book Value	209,374	207,109	218,035	192,392	199,816	217,674
Tangible Book Value Per Share	5050.93	4838.42	4932.32	4171.95	4332.92	4720.15
Order Backlog	-	3,403	2,613	2,098	1,479	2,726

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.